Adrienne Farid
Chief Operating Officer at CENTURY THERAPEUTICS, INC.
Net worth: 432 293 $ as of 2024-04-29
Profile
Adrienne Farid is currently the Chief Operations Officer at Century Therapeutics, Inc. She previously worked as a Director at Carisma Therapeutics, Inc., VP-Project Leadership at Celgene Corp., and Global Head-Project & Portfolio Management at Roche Pharmaceuticals, Inc. Farid holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-02 | 137,236 ( 0.21% ) | 432 293 $ | 2024-04-29 |
Adrienne Farid active positions
| Companies | Position | Start |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Chief Operating Officer | 2021-03-31 |
Former positions of Adrienne Farid
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 2017-06-30 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 2010-12-31 |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Adrienne Farid
| Barnard College | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CENTURY THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Stock Market
- Insiders
- Adrienne Farid